Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial

European Journal of Surgical Oncology

Volumn 41, Issue 9, 2015, Pages 1188-1196

  Verberne, C J ^a   Zhan, Z ^a   Van Den Heuvel, E ^a,m   Grossmann, I ^a,n   Doornbos, P M ^a   Havenga, K ^a   Manusama, E ^b   Klaase, J ^c   Van Der Mijle, H C J ^d   Lamme, B ^e   Bosscha, K ^f   Baas, P ^g   Van Ooijen, B ^h   Nieuwenhuijzen, G ⁱ   Marinelli, A ^j   Van Der Zaag, E ^k   Wasowicz, D ^l   De Bock, G H ^a   Wiggers, T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d NIJ SMELLINGHE HOSPITAL   (Netherlands)

^e ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^f JEROEN BOSCH HOSPITAL   (Netherlands)

^g MARTINI HOSPITAL   (Netherlands)

^h MEANDER MEDICAL CENTER   (Netherlands)

ⁱ CATHARINA HOSPITAL   (Netherlands)

^j MEDICAL CENTER HAAGLANDEN   (Netherlands)

^k GELRE HOSPITALS   (Netherlands)

^l Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^m EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

ⁿ AARHUS UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

CEA; Colorectal cancer; Follow up; Stepped wedge cluster randomized trial (SW RCT)

Indexed keywords

ANTINEOPLASTIC AGENT; FETAL ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CLINICAL PROTOCOL; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; BLOOD; CARCINOMA; CLINICAL TRIAL; COLON RESECTION; COLORECTAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL;

EID: 84938750805     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.06.008     Document Type: Article

References (38)

1. J.J. Tjandra, and M.K. Chan Follow-up after curative resection of colorectal cancer: a meta-analysis Dis Colon Rectum 50 11 2007 Nov 1783 1799
2. D.J. Bruinvels, A.M. Stiggelbout, J. Kievit, H.C. van Houwelingen, J.D. Habbema, and C.J. van de Velde Follow-up of patients with colorectal cancer. A meta-analysis Ann Surg 219 2 1994 Feb 174 182
3. M. Rosen, L. Chan, R.W. Beart Jr., P. Vukasin, and G. Anthone Follow-up of colorectal cancer: a meta-analysis Dis Colon Rectum 41 9 1998 Sep 1116 1126
4. A. Figueredo, R.B. Rumble, J. Maroun, and et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline BMC Cancer 3 2003 Oct 6 26
5. A.G. Renehan, M. Egger, M.P. Saunders, and S.T. O'Dwyer Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials BMJ 324 7341 2002 Apr 6 813
6. S. Pita-Fernandez, M. Alhayek-Ai, C. Gonzalez-Martin, B. Lopez-Calvino, T. Seoane-Pillado, and S. Pertega-Diaz Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis Ann Oncol 26 4 2015 Apr 644 656
7. M. Jeffery, B.E. Hickey, and P.N. Hider Follow-up strategies for patients treated for non-metastatic colorectal cancer Cochrane Database Syst Rev 1 2007 Jan 24 CD002200
8. J. Kievit Follow-up of patients with colorectal cancer: numbers needed to test and treat Eur J Cancer 38 7 2002 May 986 999
9. D.J. Brenner, and E.J. Hall Computed tomography - an increasing source of radiation exposure N Engl J Med 357 22 2007 Nov 29 2277 2284
10. I. Grossmann, J.K. Avenarius, W.J. Mastboom, and J.M. Klaase Preoperative staging with chest CT in patients with colorectal carcinoma: not as a routine procedure Ann Surg Oncol 17 8 2010 Aug 2045 2050
11. H.J. Staab, F.A. Anderer, E. Stumpf, and R. Fischer Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer Am J Surg 136 3 1978 Sep 322 327
12. G.Y. Locker, S. Hamilton, J. Harris, and et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J Clin Oncol 24 33 2006 Nov 20 5313 5327
13. M.J. Duffy, A. van Dalen, C. Haglund, and et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use Eur J Cancer 43 9 2007 Jun 1348 1360
14. C.J. van de Velde, C. Aristei, P.G. Boelens, and et al. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe Eur J Cancer 49 13 2013 Sep 2784 2790
15. M. Yamamoto, Y. Maehara, Y. Sakaguchi, and et al. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas Hepatogastroenterology 51 55 2004 Jan-Feb 147 151
16. I. Grossmann, G.H. de Bock, C.J. van de Velde, J. Kievit, and T. Wiggers Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow-up, treatment of metastasis, and reasons to revise follow-up practice Colorectal Dis 9 9 2007 Nov 787 792
17. R.A. Graham, S. Wang, P.J. Catalano, and D.G. Haller Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest X-ray, and colonoscopy Ann Surg 228 1 1998 Jul 59 63
18. I. Grossmann, C. Verberne, G. de Bock, and et al. The role of high frequency dynamic threshold (HiDT) serum carcinoembryonic antigen (CEA) measurements in colorectal cancer surveillance: a (revisited) hypothesis paper 3 2 2011 2302 2315
19. K. Hemming, T.P. Haines, P.J. Chilton, A.J. Girling, and R.J. Lilford The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting BMJ 350 2015 Feb 6 h391
20. K. Hemming, R. Lilford, and A.J. Girling Stepped-wedge cluster randomised controlled trials: a generic framework including parallel and multiple-level designs Stat Med 34 2 2015 Jan 30 181 196
21. Z. Zhan, E.R. van den Heuvel, P.M. Doornbos, and et al. Strengths and weaknesses of a stepped wedge cluster randomized design: its application in a colorectal cancer follow-up study J Clin Epidemiol 67 4 2014 Apr 454 461
22. C.J. Verberne, C.H. Nijboer, G.H. de Bock, I. Grossmann, T. Wiggers, and K. Havenga Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer BMC Med Inform Decis Mak 12 14 2012 Mar
23. D.J. Bentrem, R.P. Dematteo, and L.H. Blumgart Surgical therapy for metastatic disease to the liver Annu Rev Med 56 2005 139 156
24. J. Pfannschmidt, H. Dienemann, and H. Hoffmann Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series Ann Thorac Surg 84 1 2007 Jul 324 338
25. H. Kobayashi, H. Mochizuki, K. Sugihara, and et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study Surgery 141 1 2007 Jan 67 75
26. J.C. van Houwelingen Roaming through methodology. III. Randomization at the level of the physicians Ned Tijdschr Geneeskd 142 29 1998 Jul 18 1662 1665
27. F. Rodriguez-Moranta, J. Salo, A. Arcusa, and et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial J Clin Oncol 24 3 2006 Jan 20 386 393
28. R.J. de Haas, D.A. Wicherts, P. Andreani, and et al. Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection Ann Surg 253 6 2011 Jun 1069 1079
29. K.P. de Jong Review article: multimodality treatment of liver metastases increases suitability for surgical treatment Aliment Pharmacol Ther 26 Suppl. 2 2007 Dec 161 169
30. D.R. Carpizo, and M. D'Angelica Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease Lancet Oncol 10 8 2009 Aug 801 809
31. D. Hahnloser, H. Nelson, L.L. Gunderson, and et al. Curative potential of multimodality therapy for locally recurrent rectal cancer Ann Surg 237 4 2003 Apr 502 508
32. S.L. Wong, P.B. Mangu, M.A. Choti, and et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer J Clin Oncol 28 3 2010 Jan 20 493 508
33. T. Treasure, K. Monson, F. Fiorentino, and C. Russell The CEA second-look trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer BMJ Open 4 5 2014 May
34. J.N. Primrose, R. Perera, A. Gray, and et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial J Am Med Assoc 311 3 2014 Jan 15 263 270
35. P. Wille-Jorgensen, S. Laurberg, L. Pahlman, and et al. An interim analysis of recruitment to the COLOFOL trial Colorectal Dis 11 7 2009 Sep 756 758
36. E.M. Grossmann, F.E. Johnson, K.S. Virgo, W.E. Longo, and R. Fossati Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial Surg Oncol 13 2-3 2004 Aug-Nov 119 124
37. B. Bohm, W. Schwenk, H.P. Hucke, and W. Stock Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum 36 3 1993 Mar 280 286
38. I. Grossmann, P.M. Doornbos, J.M. Klaase, G.H. de Bock, and T. Wiggers Changing patterns of recurrent disease in colorectal cancer Eur J Surg Oncol 40 2 2014 Feb 234 239